用0.5%噻吗洛尔凝胶局部治疗经典型卡波西肉瘤。 - Suppr

Suppr

超能文献

Classic Kaposi's sarcoma treated with topical 0.5% timolol gel.

作者信息

Alcántara-Reifs Carmen María, Salido-Vallejo Rafael, Garnacho-Saucedo Gloria María, Vélez García-Nieto Antonio

机构信息

Resident of Dermatology, Reina Sofía University Hospital, Córdoba, Spain.

Dermatologist, Reina Sofía University Hospital, Córdoba, Spain.

出版信息

Dermatol Ther. 2016 Sep;29(5):309-311. doi: 10.1111/dth.12381. Epub 2016 Jun 21.

DOI:10.1111/dth.12381

PMID:27329079

Abstract

摘要

相似文献

Classic Kaposi's sarcoma treated with topical 0.5% timolol gel.

Dermatol Ther. 2016 Sep;29(5):309-311. doi: 10.1111/dth.12381. Epub 2016 Jun 21.

Successful treatment of classic Kaposi sarcoma with topical timolol: report of two cases.

Br J Dermatol. 2015 Sep;173(3):860-2. doi: 10.1111/bjd.13746. Epub 2015 Jul 20.

Classic and HIV-related Kaposi sarcoma treated with 0.1% topical timolol gel.

J Am Acad Dermatol. 2017 Jan;76(1):153-155. doi: 10.1016/j.jaad.2016.08.041.

Topical timolol for treatment of penile Kaposi sarcoma in HIV-negative patient.

Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12519. Epub 2017 Jul 4.

Iatrogenic Kaposi's Sarcoma Successfully Treated with Topical Timolol.

Actas Dermosifiliogr (Engl Ed). 2020 Mar;111(2):176-178. doi: 10.1016/j.ad.2018.06.024. Epub 2019 Jun 14.

Treatment of cutaneous iatrogenic Kaposi sarcoma with topical timolol.

Australas J Dermatol. 2017 Aug;58(3):242-243. doi: 10.1111/ajd.12650.

Imiquimod for the treatment of classical Kaposi's sarcoma.

Acta Derm Venereol. 2010 Jul;90(4):417-8. doi: 10.2340/00015555-0850.

Limited extent AIDS-related cutaneous Kaposi's sarcoma responsive to imiquimod 5% cream.

Int J Dermatol. 2006 Jul;45(7):854-6. doi: 10.1111/j.1365-4632.2006.02829.x.

Topical timolol for Kaposi sarcoma: An innovation.

Australas J Dermatol. 2018 Nov;59(4):340-341. doi: 10.1111/ajd.12817. Epub 2018 Apr 6.

[Kaposi's sarcoma treated with topical alitretinoin].

Actas Dermosifiliogr. 2007 Jan-Feb;98(1):50-3.

引用本文的文献

Propranolol: A Promising Therapeutic Avenue for Classic Kaposi Sarcoma.

Dermatol Pract Concept. 2025 Jan 30;15(1):4737. doi: 10.5826/dpc.1501a4737.

Fifth subtype of Kaposi sarcoma in HIV-negative MSM: a retrospective single-arm cohort study from a tertiary care center in NYC from 2000 to 2022.

Oncologist. 2025 Mar 10;30(3). doi: 10.1093/oncolo/oyaf024.

Topical treatments for Kaposi sarcoma: A systematic review.

Skin Health Dis. 2022 Apr 8;2(2):e107. doi: 10.1002/ski2.107. eCollection 2022 Jun.

Alpha and beta adrenergic receptors modulate keratinocyte migration.

PLoS One. 2021 Jul 2;16(7):e0253139. doi: 10.1371/journal.pone.0253139. eCollection 2021.

Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events.

Am J Clin Dermatol. 2021 Jan;22(1):89-99. doi: 10.1007/s40257-020-00567-3. Epub 2020 Nov 25.

Failed Treatment of Classic Kaposi's Sarcoma with Topical Timolol: Case Report and Review of the Literature.

Cureus. 2019 Dec 2;11(12):e6272. doi: 10.7759/cureus.6272.

Angiolymphoid Hyperplasia with Eosinophilia and its Response to the Combination of Radiofrequency Ablation and Topical Timolol.

Indian Dermatol Online J. 2017 Jul-Aug;8(4):267-270. doi: 10.4103/idoj.IDOJ_293_16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Classic Kaposi's sarcoma treated with topical 0.5% timolol gel.

Dermatol Ther. 2016 Sep;29(5):309-311. doi: 10.1111/dth.12381. Epub 2016 Jun 21.

Successful treatment of classic Kaposi sarcoma with topical timolol: report of two cases.

Br J Dermatol. 2015 Sep;173(3):860-2. doi: 10.1111/bjd.13746. Epub 2015 Jul 20.

Classic and HIV-related Kaposi sarcoma treated with 0.1% topical timolol gel.

J Am Acad Dermatol. 2017 Jan;76(1):153-155. doi: 10.1016/j.jaad.2016.08.041.

Topical timolol for treatment of penile Kaposi sarcoma in HIV-negative patient.

Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12519. Epub 2017 Jul 4.

Iatrogenic Kaposi's Sarcoma Successfully Treated with Topical Timolol.

Actas Dermosifiliogr (Engl Ed). 2020 Mar;111(2):176-178. doi: 10.1016/j.ad.2018.06.024. Epub 2019 Jun 14.

Treatment of cutaneous iatrogenic Kaposi sarcoma with topical timolol.

Australas J Dermatol. 2017 Aug;58(3):242-243. doi: 10.1111/ajd.12650.

Imiquimod for the treatment of classical Kaposi's sarcoma.

Acta Derm Venereol. 2010 Jul;90(4):417-8. doi: 10.2340/00015555-0850.

Limited extent AIDS-related cutaneous Kaposi's sarcoma responsive to imiquimod 5% cream.

Int J Dermatol. 2006 Jul;45(7):854-6. doi: 10.1111/j.1365-4632.2006.02829.x.

Topical timolol for Kaposi sarcoma: An innovation.

Australas J Dermatol. 2018 Nov;59(4):340-341. doi: 10.1111/ajd.12817. Epub 2018 Apr 6.

[Kaposi's sarcoma treated with topical alitretinoin].

Actas Dermosifiliogr. 2007 Jan-Feb;98(1):50-3.

引用本文的文献

Propranolol: A Promising Therapeutic Avenue for Classic Kaposi Sarcoma.

Dermatol Pract Concept. 2025 Jan 30;15(1):4737. doi: 10.5826/dpc.1501a4737.

Fifth subtype of Kaposi sarcoma in HIV-negative MSM: a retrospective single-arm cohort study from a tertiary care center in NYC from 2000 to 2022.

Oncologist. 2025 Mar 10;30(3). doi: 10.1093/oncolo/oyaf024.

Topical treatments for Kaposi sarcoma: A systematic review.

Skin Health Dis. 2022 Apr 8;2(2):e107. doi: 10.1002/ski2.107. eCollection 2022 Jun.

Alpha and beta adrenergic receptors modulate keratinocyte migration.

PLoS One. 2021 Jul 2;16(7):e0253139. doi: 10.1371/journal.pone.0253139. eCollection 2021.

Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events.

Am J Clin Dermatol. 2021 Jan;22(1):89-99. doi: 10.1007/s40257-020-00567-3. Epub 2020 Nov 25.

Failed Treatment of Classic Kaposi's Sarcoma with Topical Timolol: Case Report and Review of the Literature.

Cureus. 2019 Dec 2;11(12):e6272. doi: 10.7759/cureus.6272.

Angiolymphoid Hyperplasia with Eosinophilia and its Response to the Combination of Radiofrequency Ablation and Topical Timolol.

Indian Dermatol Online J. 2017 Jul-Aug;8(4):267-270. doi: 10.4103/idoj.IDOJ_293_16.